CPHI vs TFC · rev $4.1M vs rev $24.54B
China Pharma Holdings Inc (CPHI) versus TFC (TFC) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
TFC (TFC) common stock.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported TFC revenue for 2025-12-31 was $24.54B. Net income was $5.31B. Revenue was down 2.1% from 2024-12-31 to 2025-12-31. TFC currently screens at market cap $0.
CPHI currently screens at market cap $29.0M. TFC currently screens at market cap $0.
Not investment advice. Open the CPHI and TFC stock pages for the full models.
Not investment advice.